Position in VERU
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$11
New position
Shares Held
5
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Mar 31, 2026MATHER GROUP, LLC. holds $3,204,392 across 30 Biotechnology names. VERU ranks #30 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,438 | $1,981,744 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
581 | $448,903 | |
| 3 | MRNA |
Moderna, Inc.
|
7,645 | $388,366 | |
| 4 | INCY |
Incyte Corp
|
873 | $82,166 | |
| 5 | ARGX |
Argenx SE
|
68 | $49,657 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
73 | $38,213 | |
| 7 | INVA |
Innoviva, Inc.
|
1,500 | $34,950 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
410 | $30,786 |
All Filings in VERU
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11 | 5 | Shares | Sole | 2026-04-13 | |
| No filing history on record for this holder in this stock. | ||||||